# Innovation
Latest news and articles about Innovation
Total: 10 articles found
China's Science Ministry Outlines Plans for Major National Tech Missions
Beijing signals a systematic rollout of critical research programs and six priority focus areas to bolster self-reliance.
China Accelerates Full-Chain System for Technology Commercialization
Beijing expands manufacturing innovation centers and prepares a unified tech trading platform to move laboratory research into factory production.
Shenzhen-Hong Kong-Guangzhou Leads WIPO Global Innovation Clusters
China accounts for 25 of the world's top 100 science and technology clusters for the fourth consecutive year.
China's New Economic Drivers Index Grew 12.5 Percent in 2025, NBS Says
Industrial transformation and innovation accounted for nearly two-thirds of overall expansion as high-tech manufacturing and clean tech exports surged.
China Accelerates Construction of Major National Scientific Infrastructure
With over 70 facilities operating or under construction, regional clusters are driving fundamental physics breakthroughs and industrial applications.
Guangming Daily Commentary Highlights Innovation Vitality in Mid-Year Data
Official commentary on China's mid-year economic report emphasizes technological innovation and high-end manufacturing as key growth drivers.
China's 'Three New' Economy Reaches 18.39% of GDP in 2025, Data Shows
Output from new industries, emerging business formats, and innovative commercial models totaled 25.79 trillion yuan, outstripping overall nominal GDP growth.
Chinese Local State Enterprises Report 7% Profit Growth in First Half
State asset regulators highlight expanding R&D spending, strategic industrial realignments, and regional collaboration across provincial SOEs.
88 Shanghai-Listed Company Instances Win 2025 National Science Awards
The recognition of nearly 90 instances of Shanghai-listed firms highlights the growing role of public companies in China's 'Hard Tech' innovation strategy.
China Biopharma Advances Pipelines and Global Out-Licensing Transactions
National data and policy support highlight the sector's transition from follower-drug development to novel therapies, including ADCs.